Maven Securities »

Kymera Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.2M 15k 77.81
2025-06-30 $2.2M 50k 43.64
2020-09-30 $226k 7.1k 31.64

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Kymera Therapeutics

venBio Select Advisor
Baker Bros. Advisors
Vanguard Group
FMR
BVF
Wellington Management Company
BlackRock
Atlas Venture Life Science Advisors
Siren
State Street Corporation
Capital Research Global Investors
Geode Capital Management
Driehaus Capital Management
Ubs Global Asset Management Americas
Merck & Co

View all funds holding Kymera Therapeutics